Persistent cash burn is evident, with the company reporting a negative free cash flow of $367.2K in 2024Q4, further depleting its minimal cash reserves.
| Cash from Operations | -1.07M | -1.77M | 0 | 0 | 0 |
| Operating CF Margin % | - | -2217.4% | - | - | - |
| Operating CF Growth % | 39.54% | - | - | - | - |
| Net Income | -3.55M | -3.51M | 0 | 0 | 0 |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.48M | 1.74M | 0 | 0 | 0 |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -148.17K | -75.93K | 0 | 138.89K | -10K |
| Capital Expenditures | -3.15K | -34.5K | 0 | 0 | 0 |
| CapEx % of Revenue | - | 43.21% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 138.89K | 0 |
| Investments | - | - | - | - | - |
| Other Investing | -145.02K | -41.43K | 0 | 0 | -10K |
| Cash from Financing | 843.94K | 2.03M | 1.49M | 200 | 681.55K |
| Debt Issued (Net) | 843.94K | 721.23K | 1.49M | 200 | 57.88K |
| Equity Issued (Net) | 0 | 1000K | 0 | 0 | 300.02K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -121.84K | 0 | 0 | 323.64K |
| Net Change in Cash | -374.7K | 236.74K | -19.18K | -137.85K | 317.44K |
| Free Cash Flow | -1.22M | -1.85M | -1.51M | -276.95K | -354.11K |
| FCF Margin % | - | -2312.5% | -1022.08% | - | - |
| FCF Growth % | 34% | -22.44% | -444.48% | 21.79% | - |
| FCF per Share | - | -0.20 | -0.16 | -0.03 | -0.15 |
| FCF Conversion (FCF/Net Income) | 0.30x | 0.50x | - | - | - |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Imminent liquidity and insolvency
As reported in recent financial statements, Gelteq's operating cash flow remains consistently negative, with a 2024Q4 outflow of $302.1K, highlighting a persistent inability to convert operational activities into positive cash generation while net losses continue to mount across all observed reporting periods for the company.
The persistent gap between net income and operating cash flow suggests that the company is not generating any meaningful cash from its core business activities. Investors should monitor this trend, as the lack of positive cash conversion indicates that the current business model is fundamentally unable to sustain its own operating expenses.
Based on the company's reported figures, free cash flow has remained negative throughout the observed periods, reaching a deficit of $367.2K in 2024Q4, which underscores the ongoing cash burn required to maintain the firm's R&D and administrative infrastructure in the absence of any commercial revenue.
The trajectory of free cash flow indicates a continuous depletion of capital reserves without a corresponding path to self-sufficiency. This trend suggests that the company remains entirely dependent on external financing to cover its ongoing operational requirements and capital expenditures.
According to recent SEC filings, Gelteq's capital expenditures, while modest at $65.1K in 2024Q4, represent a significant drain on the company's dwindling cash reserves, especially given that these investments are occurring in a period where the firm is generating zero revenue from its core operations.
The allocation of capital toward equipment or infrastructure appears to be a high-risk endeavor given the lack of commercial traction. Analysts should investigate whether these expenditures are truly necessary for future growth or if they represent an inefficient use of the company's extremely limited remaining liquidity.
As indicated by the provided data, the cash flow statement reveals a critical liquidity crisis, with cash and equivalents falling to just $24,522, a figure that suggests the company may be unable to meet its near-term obligations without immediate and likely highly dilutive capital market intervention.
The lack of detail regarding working capital changes and non-cash adjustments in the provided data warrants further investigation into the company's true burn rate. The current financial position suggests that the company's operational continuity is at significant risk, and investors should be wary of the potential for rapid equity dilution.
Quick answers to the most common questions about buying GELS stock.
Gelteq Limited Ordinary Shares (GELS) generated $-1.1M in net cash from operating activities in 2024. This reflects the cash generated directly from core business operations.
Gelteq Limited Ordinary Shares (GELS) reported negative free cash flow of $1.2M in 2024, indicating capital requirements exceeded cash from operations.
Gelteq Limited Ordinary Shares (GELS) spent $0.0M on capital expenditures in 2024. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.